PL3042669T3 - Środek przeciwnowotworowy i środek wzmacniający efekt przeciwnowotworowy - Google Patents
Środek przeciwnowotworowy i środek wzmacniający efekt przeciwnowotworowyInfo
- Publication number
- PL3042669T3 PL3042669T3 PL14842538.2T PL14842538T PL3042669T3 PL 3042669 T3 PL3042669 T3 PL 3042669T3 PL 14842538 T PL14842538 T PL 14842538T PL 3042669 T3 PL3042669 T3 PL 3042669T3
- Authority
- PL
- Poland
- Prior art keywords
- cancer
- agent
- effect enhancing
- enhancing agent
- cancer effect
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Endocrinology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013184684 | 2013-09-06 | ||
| PCT/JP2014/073436 WO2015034032A1 (ja) | 2013-09-06 | 2014-09-05 | 抗腫瘍剤及び抗腫瘍効果増強剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3042669T3 true PL3042669T3 (pl) | 2023-06-26 |
Family
ID=52628493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14842538.2T PL3042669T3 (pl) | 2013-09-06 | 2014-09-05 | Środek przeciwnowotworowy i środek wzmacniający efekt przeciwnowotworowy |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US9943537B2 (pl) |
| EP (2) | EP3042669B1 (pl) |
| JP (2) | JP6425653B2 (pl) |
| KR (1) | KR101993963B1 (pl) |
| AU (1) | AU2014316030C1 (pl) |
| CY (2) | CY1126037T1 (pl) |
| DK (1) | DK3042669T3 (pl) |
| ES (1) | ES2946472T3 (pl) |
| FI (2) | FI3042669T3 (pl) |
| FR (1) | FR24C1005I1 (pl) |
| HR (1) | HRP20230523T1 (pl) |
| HU (2) | HUE062034T2 (pl) |
| LT (2) | LT3042669T (pl) |
| LU (1) | LUC00328I2 (pl) |
| NO (1) | NO2024005I1 (pl) |
| PL (1) | PL3042669T3 (pl) |
| PT (1) | PT3042669T (pl) |
| RS (1) | RS64243B1 (pl) |
| RU (1) | RU2682161C2 (pl) |
| SI (1) | SI3042669T1 (pl) |
| SM (1) | SMT202300167T1 (pl) |
| TW (1) | TWI641385B (pl) |
| UA (1) | UA121538C2 (pl) |
| WO (1) | WO2015034032A1 (pl) |
| ZA (1) | ZA201602258B (pl) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3042669T (lt) | 2013-09-06 | 2023-06-26 | Taiho Pharmaceutical Co., Ltd. | Priešvėžinis agentas ir stipriklis su priešvėžiniu poveikiu |
| US11612653B2 (en) | 2016-01-08 | 2023-03-28 | Taiho Pharmaceutical Co., Ltd. | Anti-tumor agent containing immunomodulator, and antitumor effect potentiator |
| JP2019511547A (ja) * | 2016-04-13 | 2019-04-25 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 結腸直腸癌を治療するためのニンテダニブ、トリフルリジンおよびチピラシルの医薬組合せ |
| KR102124142B1 (ko) * | 2017-06-30 | 2020-06-18 | 한국과학기술원 | VEGF-Grab 단백질과 약물의 결합체 및 이의 용도 |
| KR20220154986A (ko) | 2021-05-14 | 2022-11-22 | 윤상은 | 휴대용 마스크끈 절단기 |
| AR127893A1 (es) * | 2021-12-10 | 2024-03-06 | Servier Lab | Terapia del cáncer dirigida a egfr |
| EP4467154A4 (en) | 2022-01-21 | 2025-12-17 | Chugai Pharmaceutical Co Ltd | MEDICINE FOR THE TREATMENT OR PREVENTION OF CANCER |
| WO2023204259A1 (ja) | 2022-04-20 | 2023-10-26 | 中外製薬株式会社 | がんの治療又は予防用医薬 |
| TW202448502A (zh) * | 2023-02-20 | 2024-12-16 | 日商大鵬藥品工業股份有限公司 | Ftd・tpi調配劑、pd-1路徑拮抗劑、及vegf路徑拮抗劑之併用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0763529B1 (en) | 1995-03-29 | 2003-07-23 | Taiho Pharmaceutical Company Limited | Uracil derivatives, and antitumor effect potentiator and antitumor agent containing the same |
| US7312243B1 (en) * | 2003-08-29 | 2007-12-25 | Jay Pravda | Materials and methods for treatment of gastrointestinal disorders |
| JP5576591B2 (ja) | 2005-01-26 | 2014-08-20 | 大鵬薬品工業株式会社 | α，α，α−トリフルオロチミジンとチミジンホスホリラーゼ阻害剤とを配合した抗癌剤 |
| US7799783B2 (en) * | 2005-01-26 | 2010-09-21 | Taiho Pharmaceutical Co., Ltd. | Method of administrating an anticancer drug containing α, α, α-trifluorothymidine and thymidine phosphorylase inhibitor |
| US9616081B2 (en) | 2013-03-27 | 2017-04-11 | Taiho Pharmaceutical Co., Ltd. | Antitumor agent including low-dose irinotecan hydrochloride hydrate |
| RS60958B1 (sr) * | 2013-03-27 | 2020-11-30 | Taiho Pharmaceutical Co Ltd | Antitumorski agens koji uključuje irinotekan hidrohlorid hidrat |
| LT3042669T (lt) | 2013-09-06 | 2023-06-26 | Taiho Pharmaceutical Co., Ltd. | Priešvėžinis agentas ir stipriklis su priešvėžiniu poveikiu |
-
2014
- 2014-09-05 LT LTEPPCT/JP2014/073436T patent/LT3042669T/lt unknown
- 2014-09-05 RU RU2016112421A patent/RU2682161C2/ru active
- 2014-09-05 UA UAA201603578A patent/UA121538C2/uk unknown
- 2014-09-05 FI FIEP14842538.2T patent/FI3042669T3/fi active
- 2014-09-05 EP EP14842538.2A patent/EP3042669B1/en active Active
- 2014-09-05 SM SM20230167T patent/SMT202300167T1/it unknown
- 2014-09-05 WO PCT/JP2014/073436 patent/WO2015034032A1/ja not_active Ceased
- 2014-09-05 HU HUE14842538A patent/HUE062034T2/hu unknown
- 2014-09-05 RS RS20230421A patent/RS64243B1/sr unknown
- 2014-09-05 TW TW103130882A patent/TWI641385B/zh active
- 2014-09-05 ES ES14842538T patent/ES2946472T3/es active Active
- 2014-09-05 JP JP2015535524A patent/JP6425653B2/ja active Active
- 2014-09-05 PT PT148425382T patent/PT3042669T/pt unknown
- 2014-09-05 AU AU2014316030A patent/AU2014316030C1/en active Active
- 2014-09-05 HR HRP20230523TT patent/HRP20230523T1/hr unknown
- 2014-09-05 PL PL14842538.2T patent/PL3042669T3/pl unknown
- 2014-09-05 SI SI201432026T patent/SI3042669T1/sl unknown
- 2014-09-05 KR KR1020167005952A patent/KR101993963B1/ko active Active
- 2014-09-05 DK DK14842538.2T patent/DK3042669T3/da active
- 2014-09-05 EP EP23154967.6A patent/EP4201424A1/en active Pending
- 2014-09-05 US US14/916,878 patent/US9943537B2/en active Active
-
2016
- 2016-04-05 ZA ZA2016/02258A patent/ZA201602258B/en unknown
-
2018
- 2018-01-15 JP JP2018004516A patent/JP6557744B2/ja active Active
-
2023
- 2023-06-07 CY CY20231100271T patent/CY1126037T1/el unknown
-
2024
- 2024-01-24 FR FR24C1005C patent/FR24C1005I1/fr active Active
- 2024-01-24 LU LU00328C patent/LUC00328I2/fr unknown
- 2024-01-24 HU HUS2400001C patent/HUS2400001I1/hu unknown
- 2024-01-24 CY CY2024001C patent/CY2024001I1/el unknown
- 2024-01-25 NO NO2024005C patent/NO2024005I1/no unknown
- 2024-01-25 FI FIC20240002C patent/FIC20240002I1/fi unknown
- 2024-01-26 LT LTPA2024502C patent/LTPA2024502I1/lt unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL269045A (en) | Aptamers and uses thereof | |
| DK3043784T3 (da) | Arylethere og anvendelser deraf | |
| BR302014001267S1 (pt) | Configuração aplicada em liquidificador | |
| DK3003039T3 (da) | Methyl/fluor-pyridinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser og fluor-pyrimidinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser | |
| EP2889350A4 (en) | ADHESIVE COMPOSITION | |
| DK2962100T3 (da) | Tuberkulosebiomarkører og anvendelser deraf | |
| DK3077467T3 (da) | Sikkativsammensætning og anvendelse deraf | |
| EP2970569A4 (en) | PERSISTENT CARBENE AND COMPOSITIONS WITH IT | |
| BR302013005965S1 (pt) | Configuração aplicada em otomana | |
| PL3030519T3 (pl) | Trójpierścieniowe związki benzoksaborolu i ich zastosowania | |
| DK3027750T3 (da) | Biokatalytisk sammensætning | |
| PL3042669T3 (pl) | Środek przeciwnowotworowy i środek wzmacniający efekt przeciwnowotworowy | |
| IL240248A0 (en) | Met-binding agents and uses thereof | |
| DE112014002764A5 (de) | Schuh und Schuhset | |
| DK3071053T3 (da) | Præbiotisk sammensætning | |
| EP3041028A4 (en) | LAMINATE AND APPLICATION THEREOF | |
| EP3012307A4 (en) | MIXED REFRIGERANT | |
| BR302013005862S1 (pt) | Configuração aplicada em coador | |
| DK3068428T3 (da) | Annexin-ii-variant-sammensætninger og fremgangsmåder | |
| FR3007291B1 (fr) | Composition cicatrisante et utlisation | |
| HRP20181735T1 (hr) | Liposom za topikalnu primjenu i njegova uporaba | |
| EP2985312A4 (en) | AGGREGATE AND COMPOSITION | |
| BR302013001974S1 (pt) | Configuração aplicada em pnemático | |
| BR302013005268S1 (pt) | Configuração aplicada em muleta axilar | |
| BR302013004044S1 (pt) | Configuração aplicada em macação |